Max Delbrück Center

Predictive Systems Medicine - Partnering Event

4 Dec 2025 | Berlin, Germany

HomeParticipantsCompaniesMarketplaceAgendaProgram
Register
Register
Register

Companies

Alamar Biosciences

Other

Fremont, United States

  • Other
  • Cancer
  • Early Detection
  • Metabolic Diseases
  • Therapy Monitoring
  • Biomarker Discovery
  • Infectious Diseases
  • Neurological Diseases
  • Cardiovascular Diseases
  • Clinical Research, Trials
  • Inflammation / Autoimmune Diseases

Alamar Biosciences enables early disease detection through ultra-sensitive proteomic biomarker detection.

Bayer

Drug manufacturer

Berlin, Germany

  • Cancer
  • Neurological Diseases
  • Cardiovascular Diseases

Berlin Partner für Wirtschaft und Technologie GmbH

Other

Berlin, Germany

  • Cancer
  • Infectious Diseases
  • Neurological Diseases
  • Cardiovascular Diseases
  • Inflammation / Autoimmune Diseases

Berlin Partner unterstützt innovative Unternehmen und Startups dabei, in Berlin zu wachsen und ihre Ideen erfolgreich umzusetzen.

Charité

University / Research Organisation

  • Cancer
  • Gene Therapy
  • Cell Therapy
  • Inflammation / Autoimmune Diseases

CheckImmune GmbH

Diagnostics/Laboratory

Berlin, Germany

  • Cancer
  • Diagnostics
  • Gene Therapy
  • Cell Therapy
  • Early Detection
  • RNA-based Therapy
  • Metabolic Diseases
  • Therapy Monitoring
  • Biomarker Discovery
  • Infectious Diseases
  • Cardiovascular Diseases
  • (Single-cell) multi-omics
  • Clinical Research, Trials
  • Personalized disease models
  • Inflammation / Autoimmune Diseases
  • Data science, AI / Machine learning

CheckImmune is providing biomarker pre-clinical and clinical studies with focus on novel immunotherapeutics.

Dr. Uwe Riemer

Other

Berlin, Germany

  • Other
  • Metabolic Diseases
  • Cardiovascular Diseases

Aspiring entrepreneur in the field of life sciences consulting and Medical Affairs services

Dynamic42 GmbH

Other

Jena, Germany

  • Other
  • Other
  • Other
  • Cancer
  • Gene Therapy
  • Cell Therapy
  • Drug Screening
  • Bioengineering
  • RNA-based Therapy
  • Infectious Diseases
  • Drug Target Discovery
  • Personalized disease models
  • Inflammation / Autoimmune Diseases
  • Data science, AI / Machine learning

Dynamic42 develops human-relevant organ-on-chip models, microphysiological systems and training to improve research and cut animal testing.

EPO Berlin-Buch GmbH

University / Research Organisation

Berlin, Germany

  • Cancer
  • Cell Therapy
  • RNA-based Therapy
  • Biomarker Discovery
  • Drug Target Discovery
  • Personalized disease models
  • Data science, AI / Machine learning

CRO specialising in pre-clinical oncology

Experimental and Clinical Research Center of the Charité, Universitätsmedizin Berlin and Max Delbrück Center for Molecular Medicine

University / Research Organisation

Berlin, Germany

  • Other
  • Cancer
  • Diagnostics
  • Cell Therapy
  • Liquid Biopsy
  • Drug Screening
  • Metabolic Diseases
  • Biomarker Discovery
  • Infectious Diseases
  • Drug Target Discovery
  • Neurological Diseases
  • Cardiovascular Diseases
  • Clinical Research, Trials
  • Inflammation / Autoimmune Diseases

The mission of the ECRC is to expand and strengthen interdisciplinary activities between basic and clinician/scientists.

High-Tech Gründerfonds

Other

Berlin, Germany

  • Cancer
  • Diagnostics
  • Gene Therapy
  • Cell Therapy
  • Liquid Biopsy
  • Drug Screening
  • Bioengineering
  • Early Detection
  • RNA-based Therapy
  • Metabolic Diseases
  • Therapy Monitoring
  • Biomarker Discovery
  • Infectious Diseases
  • Drug Target Discovery
  • Neurological Diseases
  • Cardiovascular Diseases
  • (Single-cell) multi-omics
  • Clinical Research, Trials
  • Personalized disease models
  • Inflammation / Autoimmune Diseases
  • Data science, AI / Machine learning

German Venture Capital

Hochschule für Technik und Wirtschaft Berlin

University / Research Organisation

Berlin, Germany

  • Drug Screening
  • Early Detection
  • Biomarker Discovery
  • Drug Target Discovery
  • Data science, AI / Machine learning

HTW Berlin is a leading applied sciences university in Germany, focused on tech, engineering, business, and life sciences.

IBB Ventures

Other

Berlin, Germany

  • Cancer
  • Diagnostics
  • Cell Therapy
  • Bioengineering
  • RNA-based Therapy
  • Metabolic Diseases
  • Therapy Monitoring
  • Biomarker Discovery
  • Infectious Diseases
  • Neurological Diseases
  • Cardiovascular Diseases
  • (Single-cell) multi-omics
  • Clinical Research, Trials
  • Personalized disease models
  • Inflammation / Autoimmune Diseases
  • Data science, AI / Machine learning

Innovation - Made in Berlin. Investing in Berlin based startups beginning pre-seed to seed stage.

Illumina GmbH

Healthcare Solutions Provider

Berlin, Germany

  • Cancer
  • Diagnostics
  • Gene Therapy
  • Cell Therapy
  • Liquid Biopsy
  • RNA-based Therapy
  • Infectious Diseases
  • Drug Target Discovery
  • Neurological Diseases
  • (Single-cell) multi-omics
  • Clinical Research, Trials
  • Inflammation / Autoimmune Diseases
  • Data science, AI / Machine learning

Königlab - Humboldt-Universität zu Berlin

University / Research Organisation

Berlin, Germany

  • Other
  • Metabolic Diseases
  • Cardiovascular Diseases
  • Personalized disease models

Life Science Marketing Consulting - Dr. Stefanie Rösel

Other

Berlin, Germany

  • Other
  • Other
  • Other
  • Cancer
  • Diagnostics
  • Gene Therapy
  • Cell Therapy
  • Liquid Biopsy
  • Drug Screening
  • Bioengineering
  • Early Detection
  • RNA-based Therapy
  • Metabolic Diseases
  • Therapy Monitoring
  • Biomarker Discovery
  • Infectious Diseases
  • Drug Target Discovery
  • Neurological Diseases
  • Cardiovascular Diseases
  • (Single-cell) multi-omics
  • Clinical Research, Trials
  • Personalized disease models
  • Inflammation / Autoimmune Diseases
  • Data science, AI / Machine learning

Marketing and sales enablement for Life Science, Biotech and Healthcare companies and start-ups

Max Delbrück Center for Molecular Medicine

University / Research Organisation

Berlin, Germany

  • Other
  • Other
  • Cancer
  • Diagnostics
  • Gene Therapy
  • Cell Therapy
  • Liquid Biopsy
  • Drug Screening
  • Early Detection
  • RNA-based Therapy
  • Metabolic Diseases
  • Therapy Monitoring
  • Biomarker Discovery
  • Infectious Diseases
  • Drug Target Discovery
  • Neurological Diseases
  • Cardiovascular Diseases
  • Clinical Research, Trials
  • Inflammation / Autoimmune Diseases

Discovery for tomorrow's medicine

Medicover

Diagnostics/Laboratory

Stockholm, Sweden

  • Cancer
  • Gene Therapy
  • Cell Therapy
  • Liquid Biopsy
  • Early Detection
  • RNA-based Therapy
  • Infectious Diseases
  • Cardiovascular Diseases
  • Clinical Research, Trials
  • Personalized disease models
  • Inflammation / Autoimmune Diseases
  • Data science, AI / Machine learning

Medicover is a Nasdaq listed, swedish healthcare company. www.medicover.com

MyImmune Corporation

Therapeutics & Diagnostics

Wilmington, United States

  • Cancer
  • Diagnostics
  • Liquid Biopsy
  • Early Detection
  • Therapy Monitoring
  • Biomarker Discovery
  • Infectious Diseases
  • Drug Target Discovery
  • Neurological Diseases
  • Clinical Research, Trials
  • Inflammation / Autoimmune Diseases
  • Data science, AI / Machine learning

N/a

Other

Berlin, Germany

  • Inflammation / Autoimmune Diseases

Nocturne GmbH

Medical Device Manufacturer

Berlin, Germany

  • Therapy Monitoring
  • Biomarker Discovery
  • Neurological Diseases
  • Inflammation / Autoimmune Diseases
  • Data science, AI / Machine learning

AI-driven retinal biomarkers for early detection, patient stratification, and smarter clinical trials in neurological diseases.

26 results

Organisation Types

Countries

Areas of Activity

Disease Area

Biomedical Research, Medicine, Human Health

Technology